IL-4R-alpha

Class

Anti-IL-4Ralpha monoclonal antibody

Notes

original target text: IL-4 receptor alpha

Interleukin-4 receptor alpha (IL-4Rα) is a cell-surface protein that serves as the shared signaling subunit for two related cytokines, interleukin-4 (IL-4) and interleukin-13 (IL-13). These cytokines are central drivers of what immunologists call type 2 inflammation, a branch of the immune response involved in defense against parasites but also implicated in allergic disease. By binding IL-4Rα, an antibody can block signaling from both cytokines simultaneously rather than neutralizing just one, which matters because IL-4 and IL-13 have overlapping but non-identical roles in promoting antibody class-switching to immunoglobulin E, recruitment of eosinophils, mucus overproduction, and tissue remodeling seen in allergic conditions. This dual-blockade rationale distinguishes IL-4Rα-targeting antibodies from agents that inhibit only IL-13 or only IL-4, since either cytokine alone can partially sustain the inflammatory pathway if the other is left unopposed. Conditions where this mechanism is broadly relevant include atopic dermatitis, asthma with an allergic or eosinophilic component, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis, all of which are driven substantially by type 2 immune signaling. Modulating this target is a strategy for reducing chronic allergic and eosinophilic inflammation across multiple organ systems by acting on a single upstream convergence point rather than on many downstream mediators individually.